477 related articles for article (PubMed ID: 18987492)
1. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
Hardelin JP; Dodé C
Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
[TBL] [Abstract][Full Text] [Related]
3. Kallmann syndrome.
Dodé C; Hardelin JP
Eur J Hum Genet; 2009 Feb; 17(2):139-46. PubMed ID: 18985070
[TBL] [Abstract][Full Text] [Related]
4. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.
Kim SH; Hu Y; Cadman S; Bouloux P
J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870
[TBL] [Abstract][Full Text] [Related]
5. [Molecular genetics of Kallmann syndrome: an update].
Fu C; Feng Z; Liu RZ
Zhonghua Nan Ke Xue; 2011 Apr; 17(4):361-5. PubMed ID: 21548217
[TBL] [Abstract][Full Text] [Related]
6. Clinical genetics of Kallmann syndrome.
Dodé C; Hardelin JP
Ann Endocrinol (Paris); 2010 May; 71(3):149-57. PubMed ID: 20362962
[TBL] [Abstract][Full Text] [Related]
7. The recent genetics of hypogonadotrophic hypogonadism - novel insights and new questions.
Semple RK; Topaloglu AK
Clin Endocrinol (Oxf); 2010 Apr; 72(4):427-35. PubMed ID: 19719764
[TBL] [Abstract][Full Text] [Related]
8. Kallmann syndrome in women: from genes to diagnosis and treatment.
Meczekalski B; Podfigurna-Stopa A; Smolarczyk R; Katulski K; Genazzani AR
Gynecol Endocrinol; 2013 Apr; 29(4):296-300. PubMed ID: 23368665
[TBL] [Abstract][Full Text] [Related]
9. Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome.
Leroy C; Fouveaut C; Leclercq S; Jacquemont S; Boullay HD; Lespinasse J; Delpech M; Dupont JM; Hardelin JP; Dodé C
Eur J Hum Genet; 2008 Jul; 16(7):865-8. PubMed ID: 18285834
[TBL] [Abstract][Full Text] [Related]
10. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
[TBL] [Abstract][Full Text] [Related]
11. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP
PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399
[TBL] [Abstract][Full Text] [Related]
12. Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients.
Sarfati J; Fouveaut C; Leroy C; Jeanpierre M; Hardelin JP; Dodé C
Eur J Endocrinol; 2013 Dec; 169(6):805-9. PubMed ID: 24031091
[TBL] [Abstract][Full Text] [Related]
13. [Hypogonadotropic hypogonadism: new aspects in the regulation of hypothalamic-pituitary-gonadal axis].
Brioude F; Bouvattier CE; Lombès M
Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S33-41. PubMed ID: 21237329
[TBL] [Abstract][Full Text] [Related]
14. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2).
Albuisson J; Pêcheux C; Carel JC; Lacombe D; Leheup B; Lapuzina P; Bouchard P; Legius E; Matthijs G; Wasniewska M; Delpech M; Young J; Hardelin JP; Dodé C
Hum Mutat; 2005 Jan; 25(1):98-9. PubMed ID: 15605412
[TBL] [Abstract][Full Text] [Related]
15. Kallmann's syndrome, a neuronal migration defect.
Cariboni A; Maggi R
Cell Mol Life Sci; 2006 Nov; 63(21):2512-26. PubMed ID: 16952059
[TBL] [Abstract][Full Text] [Related]
16. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
Sarfati J; Dodé C; Young J
Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090
[TBL] [Abstract][Full Text] [Related]
17. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
[TBL] [Abstract][Full Text] [Related]
18. [Kallmann syndrome: a historical [corrected] clinical and molecular review].
Ribeiro RS; Abucham J
Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):8-17. PubMed ID: 18345392
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of disease: Insights into X-linked and autosomal-dominant Kallmann syndrome.
Tsai PS; Gill JC
Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):160-71. PubMed ID: 16932275
[TBL] [Abstract][Full Text] [Related]
20. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia.
Trarbach EB; Costa EM; Versiani B; de Castro M; Baptista MT; Garmes HM; de Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2006 Oct; 91(10):4006-12. PubMed ID: 16882753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
